Table 3.
Healing time | Age (years) | Gender | GCS | Injury type | Callus volume (cm3) | Density of NGF+ cells (Num/0.01 mm2) | Density of VEGF+ cells | Density of CD31+ cells (positive area/total field area) | ||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Healing time (days) | r | 1 | 0.110 | −0.047 | 0.765** | −0.747** | −0.632** | −0.837** | −0.831** | −0.847** |
P | 0.467 | 0.757 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||
Age (years) | r | 0.110 | 1 | 0.049 | 0.089 | −0.066 | 0.043 | −0.052 | −0.134 | −0.057 |
P | 0.467 | 0.748 | 0.558 | 0.662 | 0.777 | 0.729 | 0.373 | 0.705 | ||
Gender | r | −0.047 | 0.049 | 1 | −0.043 | 0.040 | 0.075 | 0.063 | 0.089 | 0.168 |
P | 0.753 | 0.748 | 0.778 | 0.790 | 0.622 | 0.677 | 0.557 | 0.264 | ||
GCS | r | 0.765** | 0.089 | −0.043 | 1 | −0.884** | −0.819** | −0.932** | −0.901** | −0.785** |
P | 0.000 | 0.558 | 0.778 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||
Injury type | r | −0.747** | −0.066 | 0.040 | −0.884** | 1 | 0.708** | 0.951** | 0.966** | 0.813** |
P | 0.000 | 0.662 | 0.790 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||
Callus volume (cm3) | r | −0.632** | 0.043 | 0.075 | −0.819** | 0.708** | 1 | 0.774** | 0.726** | 0.677** |
P | 0.000 | 0.777 | 0.622 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||
Density of NGF+ cells (Num/0.01 mm2) | r | −0.837** | −0.052 | 0.063 | −0.932** | 0.951** | 0.774** | 1 | 0.972** | 0.879** |
P | 0.000 | 0.729 | 0.677 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||
Density of VEGF+ cells (Num/0.01 mm2) | r | –0.831** | −0.134 | 0.089 | −0.901** | 0.966** | 0.726** | 0.972** | 1 | 0.864** |
P | 0.000 | 0.373 | 0.557 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||
Density of CD31+ cells (positive area/total field area) | r | –0.847** | −0.057 | 0.168 | −0.785** | 0.785** | 0.677** | 0.879** | 0.864** | 1 |
P | 0.000 | 0.705 | 0.264 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
Notes:
Correlation is significant at the level of P<0.01 (two-tailed).
Abbreviations: GCS, Glasgow Coma Scale; NGF, nerve growth factor; VEGF, vascular endothelial growth factor.